Collaborates with Visa to offer 'Jubilant Red Christmas Spending Rewards' with Cash Rebates and Lucky Draw Entries — To mark its 20th anniversary, Link is launching a “Jubilant Red Christmas” campaign across 20 of its malls, featuringred-themed décor and optical illusion art installations, candy-themed photo spots and festive Jelly Belly scenes. — Link is partnering […]
NEW YORK CITY, NY / ACCESS Newswire / November 23, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against MoonLake Immunotherapeutics ("Moonlake" or the "Company") (NASDAQ:MLTX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged
(NYSE:HRL), NEW YORK, Nov. 23, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Hormel Foods Corporation (NYSE: HRL) resulting from allegations that Hormel may have issued materially misleading business information to the investing public. SO WHAT: If
HRL Investor News: If You Have Suffered Losses in Hormel Foods Corporation (NYSE: HRL), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire November 24, 2025 NEW YORK, Nov. 23, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims
(NASDAQ:FFAI), The FX Super One and FF 91 2.0 will participate in the LA Auto Show, where our ride-along experiences begin. The Company welcomes everyone to give them a try and place preorders. LOS ANGELES, Nov. 23, 2025 (GLOBE NEWSWIRE) — Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a
Faraday Future Founder and Co-CEO YT Jia Shares Weekly Investor Update: FF Completes its “Dual Flywheel, Dual Bridge, and Dual Listed-Company” Structure; First batch of FX Super One Complete Sets of Components to Arrive at Port of Long Beach Next Week GlobeNewswire November 24, 2025 The FX Super One and FF 91 2.0 will participate
NEW YORK, NY / ACCESS Newswire / November 23, 2025 / If you suffered a loss on your Freeport-McMoRan Inc. (NYSE:FCX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/freeport-mcmoran-inc-lawsuit-submission-form?prid=178811&wire=1&utm_campaign=12 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
NEW YORK, NY / ACCESS Newswire / November 23, 2025 / If you suffered a loss on your Baxter International, Inc. (NYSE:BAX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/baxter-international-inc-lawsuit-submission-form?prid=178809&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
New York, New York–(Newsfile Corp. – November 23, 2025) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Freeport-McMoRan Inc. (NYSE: FCX) between February 15, 2022 and September 24, 2025, both dates inclusive (the “Class Period”), of the important January 12, 2026 lead plaintiff deadline in the securities
Harbour BioMed (“HBM” or the “Company”; HKEX: 02142), a global biopharmaceutical company committed to the discoveryand development of novel antibody therapeutics for immunology and oncology, today announced an update and advancement of its global strategic collaboration with AstraZeneca, originally established in March 2025. The collaboration aims to discover and develop next-generation biotherapeutics, including antibody-drug conjugates